Showing 91-100 of 2293 results for "".
Pediatric-Onset Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/pediatric-onset-multiple-sclerosis/30128/Information from clinical trials in children with MS is furthering understanding and improving treatment options for this rare presentation.Therapeutics Q&A:
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/therapeutics-qa/30861/The first drug approved specifically to manage a symptom of MS is shown to improve patients' walking ability.- Expert Opinionhttps://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/PN0305ExpertOpinion-pdf/31480/Does “Benign” Multiple Sclerosis Really Exist? A Clinical AnalysisIn the March 2005 issue of *Practical Neurology*, Dr. George G. Hutton provides an expert opinion on the existence and diagnosis of benign multiple sclerosis (MS) through the examination of a 53-year-old male patient. The case centers
- Detecting Subtle Multiple Sclerosis Mimickershttps://practicalneurology.com/columns/practice-management/detecting-subtle-multiple-sclerosis-mimickers/31415/Differentiating Multiple Sclerosis from Its Mimicking Conditions: A Comprehensive OverviewDiagnosing multiple sclerosis (MS) remains one of the most challenging tasks in neurology due to the existence of over 100 conditions that can present with similar clinical features. While general practitioners
Vitamin D: Considerations for Treatment, Prevention, and Risk in Multiple Sclerosis Care
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/vitamin-d-considerations-for-treatment-prevention-and-risk-in-multiple-sclerosis-care/30373/Preliminary signals are strong that vitamin D has a role to play in MS, but more research is needed to confirm the need for supplementation as a preventive or therapeutic measure.Diagnostic Q&A: Optical Coherence Tomography and Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/diagnostic-qa-using-optical-coherence-tomography-to-diagnose-multiple-sclerosis/30823/New findings suggest a novel in-office imaging technique can help identify MS patients who are likely to have increased disease severity. An investigator explains.Promising Directions in Relapse-Impact Prevention in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/promising-directions-in-relapse-impact-prevention-in-multiple-sclerosis/30520/Current immunomodulatory treatments for MS are not reliable to prevent long-term disability, but future agents focusing on remyelination and axonal and neuronal repair could reverse this course.- What Will Be Tysabri's Fate?https://practicalneurology.com/columns/practice-management/what-will-be-tysabris-fate/31328/Natalizumab (Tysabri) in Multiple Sclerosis: Breakthroughs and ChallengesOver the past decades, advancements in understanding multiple sclerosis (MS) pathogenesis have paved the way for targeted therapies aimed at disrupting the inflammatory processes that drive central nervous system (CNS) inflamma
- Keeping Tysabri Therapy on Targethttps://practicalneurology.com/columns/practice-management/keeping-tysabri-therapy-on-target/31170/Natalizumab (Tysabri) in Multiple Sclerosis: Balancing Efficacy and SafetyOne year following its reintroduction to the market, natalizumab (Tysabri) continues to be a focal point for multiple sclerosis (MS) specialists striving to optimize its use while mitigating associated risks. Originally withdr
About the Cover Artist: Fatherhood by Bevan Choate, MD
https://practicalneurology.com/diseases-diagnoses/stroke/about-the-cover-artistifatherhoodi-by-bevan-choate-md/32198/Dr. Choate, a practicing urologist, turned to art while recovering from a stroke he experienced at age 35. He continues to use his art to advocate for those affected by brain injury.